One MORE for Chronic Pain

Not Applicable

Completed

• Conditions: Chronic Pain
• Interventions: Behavioral: One MORE

• Registration Number: NCT05194241
• Lead Sponsor: University of Utah

Brief Summary

This study will be a single-site, two-arm randomized controlled trial conducted among chronic pain patients. Chronic pain patients will be randomized by a computer-generated randomization schedule with simple random allocation (1:1) to either One MORE or a wait-list control condition (WLC). One MORE will be delivered individually via a HIPAA compliant virtual meeting platform.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-11-16
• Study Start: 2021-11-18
• Study First Submitted QC: 2022-01-03
• Study First Posted: 2022-01-18
• Primary Completion: 2022-11-27
• Study Completion: 2022-11-27
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-14
• Last Update Posted: 2023-03-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• men/women ≥18 years of age
• current chronic pain diagnosis
• reporting pain ≥3 on 0-10 scale

Exclusion Criteria

• unstable illness judged by clinician to interfere with study participation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
One MORE	One MORE	-

Primary Outcome Measures

Name	Time	Method
Pain Catastrophizing	Will be completed at baseline, week 2, and 1, 2, and 3 months after baseline.	Change in pain catastrophizing from baseline through 3-month follow-up will be assessed with the Pain Catastrophizing Scale. Scores range from 0 to 52, with higher scores reflecting greater pain catastrophizing.

Secondary Outcome Measures

Name	Time	Method
Pain Intensity	Will be completed at baseline, week 2, and 1, 2, and 3 months after baseline.	Change in pain intensity from baseline through 3-month follow-up will be assessed with the Pain, Enjoyment, and General Activity scale. Scores range from 0 to 10, with higher scores reflecting greater pain intensity.
Pain Interference	Will be completed at baseline, week 2, and 1, 2, and 3 months after baseline.	Change in pain interference from baseline through 3-month follow-up will be assessed with the Pain, Enjoyment, and General Activity scale. Scores range from 0 to 20, with higher scores reflecting greater pain interference.

Trial Locations

Locations (1)

University of Utah; 🇺🇸 Salt Lake City, Utah, United States